Optic Nerve Neoplasms: Clinical Trials

21 trials for Optic Nerve Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 terminated, 1 active not recruiting, 1 recruiting. 21 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 221Completed 16, Terminated 3, Active not recruiting 1, Recruiting 1
Phase 14Completed 2, Active not recruiting 1, Terminated 1

Follow Optic Nerve Neoplasms: new trials by email Literature Review of Optic Nerve Neoplasms trials Research Report on Optic Nerve Neoplasms

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modified CV Regimen in Optic Pathway Glioma
Carboplatin, Vincristine, Recombinant human endostatin - Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma
Phase 2RecruitingBeijing Sanbo Brain Hospital752022-04-132024-10-15
Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours
Selumetinib - Neurofibromatosis Type 1, Plexiform Neurofibroma
Phase 1 / Phase 2CompletedGreat Ormond Street Hospital for Children NHS Foundation Trust142019-09-262024-04-04
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
Laboratory Biomarker Analysis, Selumetinib Sulfate - Cutaneous Neurofibroma, Neurofibromatosis Type 1
Phase 2CompletedNational Cancer Institute (NCI)112017-08-262023-12-06
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma
Phase 2TerminatedWashington University School of Medicine62015-08-142024-11-01
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Photofrin photodynamic therapy. - Brain Tumor, Recurrent
Phase 2TerminatedHarry T Whelan, MD12015-06-012019-08-20
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Mebendazole, Vincristine, Carboplatin - Pilomyxoid Astrocytoma, Pilocytic Astrocytoma
Phase 1 / Phase 2Active not recruitingJulie Krystal102013-10-222026-08-06
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Lenalidomide, Pharmacological Study - Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma
Phase 2CompletedNational Cancer Institute (NCI)752012-07-052025-01-07
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1 / Phase 2TerminatedCity of Hope Medical Center72008-09-102026-11-04
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
cilengitide, laboratory biomarker analysis, pharmacological study - Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma
Phase 2CompletedNational Cancer Institute (NCI)302008-06-012018-08-01
Radiation Therapy in Treating Young Patients With Gliomas
radiation therapy - Brain Tumor, Central Nervous System Tumor
Phase 2CompletedChildren's Oncology Group922006-11-012019-08-07
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
DNA analysis, immunologic technique, pharmacological study - Brain and Central Nervous System Tumors, Intraocular Melanoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center782006-01-012024-04-04
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
oxaliplatin - Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)1802004-10-012013-06-05
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
tipifarnib - Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma
Phase 2CompletedNational Cancer Institute (NCI)902003-11-012013-10-08
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
cyproheptadine hydrochloride, megestrol acetate - Brain Tumor, Central Nervous System Tumors
Phase 2CompletedUniversity of South Florida702003-06-012014-02-03
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
filgrastim, temozolomide, peripheral blood stem cell transplantation - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1 / Phase 2CompletedDuke University302000-08-012013-06-20
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
becatecarin - Brain and Central Nervous System Tumors, Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)2002000-07-012013-02-05
Irinotecan in Treating Children With Refractory Solid Tumors
irinotecan hydrochloride - Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor
Phase 2CompletedChildren's Oncology Group1811999-10-012013-06-14
Lobradimil and Carboplatin in Treating Children With Brain Tumors
carboplatin, lobradimil - Brain and Central Nervous System Tumors
Phase 2CompletedNational Cancer Institute (NCI)1998-03-012013-08-16
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
temozolomide - Brain and Central Nervous System Tumors
Phase 2CompletedDuke University1001998-03-012014-07-09
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
cisplatin, doxorubicin hydrochloride, tamoxifen citrate - Adrenocortical Carcinoma, Brain and Central Nervous System Tumors
Phase 2CompletedOttawa Regional Cancer Centre301994-05-012013-07-10

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Optic Nerve Glioma (21)  ·  Astrocytoma (18)  ·  Oligodendroglioma (14)  ·  Central Nervous System Neoplasms (10)  ·  Familial ependymoma (9)  ·  Medulloblastoma (9)  ·  Brain Neoplasms (7)  ·  Glioma (6)  ·  Neuroblastoma (6)  ·  Choroid Plexus Neoplasms (5)  ·  Glioblastoma (5)  ·  Neuroectodermal Tumors, Primitive, Peripheral (5)  ·  Sarcoma (5)  ·  Osteosarcoma (4)  ·  Burkitt Lymphoma (3)

Broader conditions

Cranial Nerve Diseases (21)  ·  Cranial Nerve Neoplasms (21)  ·  Eye Diseases (21)  ·  Neoplasms (21)  ·  Neoplasms by Histologic Type (21)  ·  Neoplasms by Site (21)  ·  Neoplasms, Glandular and Epithelial (21)  ·  Neoplasms, Nerve Tissue (21)  ·  Nervous System Diseases (21)  ·  Nervous System Neoplasms (21)  ·  Neuroectodermal Tumors (21)  ·  Optic Nerve Diseases (21)  ·  Peripheral Nervous System Neoplasms (21)  ·  Neoplasms, Germ Cell and Embryonal (20)

Interventions

Carboplatin (5)  ·  Radiotherapy (3)  ·  Temozolomide (3)  ·  Doxorubicin (2)  ·  Irinotecan (2)  ·  Vincristine (2)  ·  etoposide phosphate (2)  ·  AZD 6244 (1)  ·  Bevacizumab (1)  ·  Blotting, Western (1)  ·  Cilengitide (1)  ·  Cisplatin (1)  ·  Cyproheptadine (1)  ·  Dasatinib (1)  ·  Dynamic Contrast Enhanced Magnetic Resonance Imaging (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  Duke University (3)  ·  Children's Oncology Group (2)  ·  Beijing Sanbo Brain Hospital (1)  ·  City of Hope Medical Center (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Harry T Whelan, MD (1)  ·  Julie Krystal (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Ottawa Regional Cancer Centre (1)  ·  University of South Florida (1)  ·  Washington University School of Medicine (1)

Countries

United States (18)  ·  Canada (8)  ·  Australia (4)  ·  New Zealand (4)  ·  Puerto Rico (4)  ·  Switzerland (3)  ·  Netherlands (2)  ·  China (1)  ·  United Kingdom (1)

Top investigators

Henry S. Friedman, MD (3)  ·  Andrew Cluster, M.D. (1)  ·  Anne-Marie Langevin, MD (1)  ·  Bruce R Korf (1)  ·  Darren Hargrave, MB Bch (1)  ·  Edward G. Shaw, MD (1)  ·  Harry T Whelan, MD (1)  ·  Jennifer L. Mayer, MD (1)  ·  Joel M. Cherlow, MD (1)  ·  Judith K. Sato, MD (1)  ·  Julie Krystal, MD (1)  ·  Katherine E Warren (1)  ·  Katherine Warren, MD (1)  ·  Kim Kramer, MD (1)  ·  Lisa Bomgaars (1)

Results publications

PMID 16408203, PMID 17610262, PMID 18989154, PMID 20381270, PMID 37126770, PMID 38907342, PMID 40009403

NIH funding

U10CA098543 (5), P30CA013148 (1), P30CA033572 (1), U10CA081920 (1), U10CA180886 (1)